Mark Fleharty is the Associate Director of Translational Analytics at the Broad Institute of MIT and Harvard. He leads a team building advanced NGS pipelines for liquid biopsy assays, particularly focused on applications in pediatric oncology. He earned his PhD in Nanoscience and Microsystems from The University of New Mexico.
There is no publicly available information about Marks personal life, hobbies, or non-work-related activities. His professional work and academic background are the primary focus of the available data.
His team develops pipelines to accurately detect somatic events from liquid biopsies, a technology with the potential to revolutionize precision medicine in cancer by enabling less invasive diagnostics.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.